Physician profile
Jonathan Asher Morgan
NPI 1508850165
$438.22
in general payments reported to CMS, 2019-2025
11 companies · $31.90 in 2025
The $31.90 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $20.22 · 2022: $99.95 · 2024: $141 · 2025: $31.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $172.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $140.83 | 2024 | Freestyle Libre 3 |
| Incyte Corporation | $99.95 | 2022 | |
| Janssen Biotech, INC. | $38.43 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $33.73 | 2019-2020 | |
| Agios Pharmaceuticals, INC. | $31.90 | 2025 | Pyrukynd |
| Celgene Corporation | $19.86 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $16.65 | 2019 | |
| Philips North America LLC | $15.68 | 2019 | |
| Abbvie INC. | $14.52 | 2019 | |
| Puma Biotechnology, INC. | $14.42 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.